Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 7/20 | 0.48 |
| ▸ | BBOX1 | O75936 | 2/20 | 0.45 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | APP | P05067 | 1/20 | 0.39 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | GRK2 | P25098 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL1271206 | 0.98 | DNM1 (0.46) | DNM1BBOX1HTTAPPENPP2 | |
| SCHEMBL15305905 | 0.94 | DNM1 (0.52) | DNM1BBOX1HTTAPPKMT2A | |
| SCHEMBL30200232 | 0.92 | DNM1 (0.50) | DNM1BBOX1HTTAPPKMT2A | |
| SCHEMBL15382997 | 0.91 | DNM1 (0.50) | DNM1BBOX1HTTAPPENPP2 | |
| SCHEMBL918271 | 0.91 | BBOX1 (0.46) | DNM1BBOX1HTTAPPLMNA | |
| SCHEMBL10937742 | 0.88 | HTT (0.60) | DNM1HTTENPP2KMT2ALMNA | |
| SCHEMBL60618 | 0.88 | HTT (0.60) | DNM1HTTENPP2KMT2ALMNA | |
| SCHEMBL10933953 | 0.88 | HTT (0.60) | DNM1HTTENPP2KMT2ALMNA | |
| SCHEMBL16604562 | 0.88 | HTT (0.60) | DNM1HTTENPP2KMT2ALMNA | |
| SCHEMBL10975956 | 0.88 | HTT (0.60) | DNM1HTTENPP2KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119038790-A | Waste water recovery method for silane coupling agent production workshop | 永修县艾科普新材料有限公司 | 2024-11-29 | — | — | CN | disclosed |
| WO-2024077009-A1 | FUNCTIONALIZED MACROMOLECULES AND SYSTEMS, METHODS OF SYNTHESIS, AND USES THEREOF | SEER, INC. (US) | 2024-04-11 | — | — | WO | disclosed |
| EP-2493512-B1 | TREATING WATER INSOLUBLE NANOPARTICLES WITH HYDROPHILIC ALPHA-HYDROXYPHOSPHONIC ACID CONJUGATES, THE SO MODIFIED NANOPARTICLES AND THEIR USE AS CONTRAST AGENTS | GEN ELECTRIC (US) | 2019-01-23 | — | — | EP | disclosed |
| US-9827335-B2 | Treating water insoluble nanoparticles with hydrophilic alpha-hydroxyphosphonic acid conjugates, the so modified nanoparticles and their use as contrast agents | GENERAL ELECTRIC COMPANY (US) | 2017-11-28 | — | — | US | disclosed |
| US-20170175051-A1 | Occult Particles For Use In Granular Laundry Care Compositions | MILLIKEN & COMPANY (US) | 2017-06-22 | — | — | US | disclosed |
| US-9487750-B2 | Methods and compositions for growth of cells and embryonic tissue on a synthetic polymer matrix | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2016-11-08 | — | — | US | disclosed |
| US-20160038617-A1 | TREATING WATER INSOLUBLE NANOPARTICLES WITH HYDROPHILIC ALPHA-HYDROXYPHOSPHONIC ACID CONJUGATES, THE SO MODIFIED NANOPARTICLES AND THEIR USE AS CONTRAST AGENTS | GENERAL ELECTRIC COMPANY | 2016-02-11 | — | — | US | disclosed |
| US-9205155-B2 | Treating water insoluble nanoparticles with hydrophilic alpha-hydroxyphosphonic acid conjugates, the so modified nanoparticles and their use as contrast agents | GENERAL ELECTRIC COMPANY (US) | 2015-12-08 | — | — | US | disclosed |
| US-20150105312-A1 | Colored Speckles For Use In Granular Detergents | MILLIKEN & COMPANY | 2015-04-16 | — | — | US | disclosed |
| US-8900205-B2 | Syringe for prefilled syringe | TERUMO KABUSHIKI KAISHA (JP) | 2014-12-02 | — | — | US | disclosed |
| US-20140255861-A1 | METHODS AND COMPOSITIONS FOR GROWTH OF CELLS AND EMBRYONIC TISSUE ON A SYNTHETIC POLYMER MATRIX | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2014-09-11 | — | — | US | disclosed |
| US-20130197451-A1 | SYRINGE FOR PREFILLED SYRINGE | TERUMO KABUSHIKI KAISHA (JP) | 2013-08-01 | — | — | US | disclosed |
| US-8470760-B2 | Colored speckles for use in granular detergents | Milliken 7 Company (US) | 2013-06-25 | — | — | US | disclosed |
| US-20130102023-A1 | METHODS AND COMPOSITIONS FOR GROWTH OF CELLS AND EMBRYONIC TISSUE ON A SYNTHETIC POLYMER MATRIX | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2013-04-25 | — | — | US | disclosed |
| EP-2493512-A2 | TREATING WATER INSOLUBLE NANOPARTICLES WITH HYDROPHILIC ALPHA-HYDROXYPHOSPHONIC ACID CONJUGATES, THE SO MODIFIED NANOPARTICLES AND THEIR USE AS CONTRAST AGENTS | General Electric Company (US) | 2012-09-05 | — | — | EP | disclosed |
| US-20110294716-A1 | Colored Speckles For Use In Granular Detergents | MILLIKEN & COMPANY | 2011-12-01 | — | — | US | disclosed |
| WO-2011051422-A2 | TREATING WATER INSOLUBLE NANOPARTICLES WITH HYDROPHILIC ALPHA-HYDROXYPHOSPHONIC ACID CONJUGATES, THE SO MODIFIED NANOPARTICLES AND THEIR USE AS CONTRAST AGENTS | GENERAL ELECTRIC COMPANY (US) | 2011-05-05 | — | — | WO | disclosed |
| US-20110104072-A1 | TREATING WATER INSOLUBLE NANOPARTICLES WITH HYDROPHILIC ALPHA-HYDROXYPHOSPHONIC ACID CONJUGATES, THE SO MODIFIED NANOPARTICLES AND THEIR USE AS CONTRAST AGENTS | GENERAL ELECTRIC COMPANY (US) | 2011-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110104072-A1 | TREATING WATER INSOLUBLE NANOPARTICLES WITH HYDROPHILIC ALPHA-HYDROXYPHOSPHONIC ACID CONJUGATES, THE SO MODIFIED NANOPARTICLES AND THEIR USE AS CONTRAST AGENTS | HAMP, SLC46A1, CD44 | DNM1 2211/4885BBOX1 3089/4885HTT 899/4885 |
| US-20160038617-A1 | TREATING WATER INSOLUBLE NANOPARTICLES WITH HYDROPHILIC ALPHA-HYDROXYPHOSPHONIC ACID CONJUGATES, THE SO MODIFIED NANOPARTICLES AND THEIR USE AS CONTRAST AGENTS | HAMP, SLC46A1, CD44 | DNM1 2211/4885BBOX1 3089/4885HTT 899/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.